Society for Evidence-Based Gender Medicine
Letters to WHO from the Society for Evidence Based Gender Medicine (SEGM), which has itself commissioned several forthcoming relevant systematic reviews, and the Clinical Advisory Network on Sex and Gender (CAN-SG), a network of mainly UK and Irish clinicians, raised the question of whether WHO would be evaluating the benefits and harms of hormonal treatments for gender incongruence—or if instead it “has taken a policy position on this without critically appraising the evidence,” as a letter fro
Basic Information
- Category: advocacy group
- Website: https://segm.org/
Documented Facts
- Email: contact@segm.org (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore advocacy group profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Society for Evidence-Based Gender Medicine.
- Canonical profile: https://brandsource.ai/brands/society-for-evidence-based-gender-medicine
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/society-for-evidence-based-gender-medicine/json-ld
- Citation profile API: https://brandsource.ai/api/brands/society-for-evidence-based-gender-medicine/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-23
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Letters to WHO from the Society for Evidence Based Gender Medicine (SEGM), which has itself commissioned several forthcoming relevant systematic reviews, and the Clinical Advisory Network on Sex and Gender (CAN-SG), a network of mainly UK and Irish clinicians, raised the question of whether WHO would be evaluating the benefits and harms of hormonal treatments for gender incongruence—or if instead it “has taken a policy position on this without critically appraising the evidence,” as a letter fro
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.